Open Prospective Study to Evaluate the Efficacy of a New Vaginal Pessary Containing 300mg Tinidazole, 200mg Tioconazole and 100mg Lidocaine with a 3-day Regime (GynomaxXL®) in the Treatment of Vaginal Infections due to Bacterial Vaginosis, Candidiasis and Mixed Infections

Regidor Pa and M Sailer
Additional contact information
M Sailer: Department of Gynecology and Obsterics, Germany

Biomedical Journal of Scientific & Technical Research, 2019, vol. 12, issue 5, 1-11

Abstract: The management of infections of the vulva and vagina depend on the selection and administration of effective specific therapies that allow a fast treatment, enhancing the compliance of the patients.

Keywords: Biomedical Sciences; Biomedical Research; Technical research; Candidiasis; Bacterial Vaginosis; Mixed Vaginal Infections; Tinidazole; Tioconazol (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.002327.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.002327.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:12:y:2019:i:5:p:1-11

DOI: 10.26717/BJSTR.2019.12.002327

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().